banner

Nagu saabsan

Xogta Shirkadda

Innovita Biological Technology Co., Ltd. , Innovita (Beijing) iyo Innovita (Guangzhou).

● Waxaa la aasaasay 2006

● Ka samee xarumaha R&D ee Beijing iyo Guangzhou, iyo saldhiga wax soo saarka ee Qian'an, Hebei

about-us (3)
about-us (23)

Xogta Shirkadda

Waxaa la aasaasay 2006, INNOVITA waxay dhistay lix goobood oo farsamo sida antigen & diyaarinta antibody, dhaqanka fayraska, dahabka kolloidal, ELISA, chromatography fluorescence, immunofluorescence, waxayna qabataa barnaamijka R&D ee Qaranka Shiinaha ee heer qaran ee cilmi baarista cudurada faafa iyo kuwa badan. mashaariicda kale ee caafimaadka dadweynaha.Ka sokow, INNOVITA waxay leedahay in ka badan toban shati-hal-abuur qaran waxayna dejisay xarunta R&D ee Beijing, xarunta Guangzhou R&D, saldhigga wax soo saarka Hebei.Iyada oo leh aqoon-is-weydaarsiyo waaweyn oo nadiif ah, iyo dejinta dahab kolloidal ah, ELISA, chromatography fluorescence, PCR, khadadka soosaarka immunofluorescence, INNOVITA waxay heshay shahaadada CE iyo ISO13485.

Waqtigan xaadirka ah, alaabada INNOVITA waxay ka kooban tahay baaritaannada ogaanshaha neefsashada, baaritaanka dhalmada, baarista cagaarshowga, baarista TORCH, baaritaannada wadnaha iyo xididdada, baaritaannada shaqada kelyaha iyo wixii la mid ah.Shabakadda iibka ayaa daboolay dhammaan gobollada iyo gobollada Shiinaha, waxayna ku fiday Koonfur-bari Aasiya, Bariga Dhexe, Afrika, Latin America, Midowga Yurub iyo gobollada kale ee dibadda.INNOVITA waxay raacdaa falsafada ganacsi ee udub dhexaad u ah macaamiisha, waxayna u adeegtaa macaamiisha alaab sax ah oo ku haboon.Baahida macaamiishu waa raadinta INOVITA.

Habka Horumarinta

  • Sannadkii 2006dii
    ● Xarunta R&D ee Beijing oo la aasaasay.
  • Sannadkii 2011kii
    ● Tangshan wax soo saarka oo la aasaasay.
  • 2014kii
    ● ISO 13485 waa la xaqiijiyay.
  • Sanadka 2018-ka
    Maalgelinta istiraatiijiyadeed ee Genesis Capital.
    ● Wuxuu bilaabay iskaashi farsamo oo caalami ah.
  • 2019ka
    Maalgelinta istiraatiijiyadeed ee Sequoia Capital.
  • 2020
    ● Marka hore NMPA ogolaatay COVID-19 IgM/IgG Combo Test.
    ● Loo dhoofiyay in ka badan 70 waddan/goobo.
    ● Waxaa Lagu Abaalmariyay Wadari Sarreeyey Golaha Ammaanta Qaranka ee La-dagaalanka Faafida COVID-19.
    ● Tijaabada COVID-19 IgM/IgG waxay heshay Oggolaanshaha Isticmaalka Degdegga ah (EUA) ee US FDA.
  • 2022
    ● Kulanka ugu horreeya ee lagu daah-furayo suuqa SSE STAR, waxaana dhawaan lagu qori doonaa guddiga hal-abuurka farsamada ee Shiinaha.
  • Laamaha

    about-us (7)

    Beijing R&D & Xarunta Suuqgeynta

    Dhisidda:2006

    Diirada saar:R&D, wax-soo-saarka, suuq-geynta badeecada ogaanshaha in-vitro, oo ay ku jiraan aaladaha ay ka midka yihiin tallaalka difaaca jirka, ogaanshaha molecular, iyo chips-ka hidda-socodka.

    Xarunta Waxsoosaarka & Saadka ee Qian'an

    Dhisidda:2011

    Xarunta:Daboolka aagga 150 acres, agagaarka 8,000 ㎡ aagga aqoon-is-weydaarsiga, oo ku qalabaysan khadadka wax-soo-saarka badan ee dahabka kolloidka, ELISA, PCR.

    shahaadoISO 13485, CE, FDA, NMPA, iwm.

    Xarunta R&D ee Guangzhou

    Dhisidda:2020

    Diirada saar:R&D ee tignoolajiyada IVD

    Platform

    plate

    Shabakadda Suuqgeynta

    Sanado badan oo horumarineed ka dib, Innovita waxay horey u haysataa shabakad iib iyo adeeg dhammaystiran, oo leh kanaalada iibka ee daboolaya 32 gobol iyo gobollada Shiinaha oo dhan, waxayna u dhoofisay suuqyada adduunka sida Koonfur-bari Aasiya, Bariga Dhexe, Afrika, Latin America, Yurub, iwm.

    Tijaabada Innovita 2019-nCoV Ab ayaa lagu soo bandhigay goobta gurmadka qaranka ee daawooyinka iyo aaladaha caafimaadka

    Febraayo 28, 2020, Raiisel wasaaraha Li Keqiang wuxuu kormeeray goobta gurmadka qaran ee dawooyinka iyo aaladaha caafimaadka ee COVID-19.Imtixaanka Innovita 2019-nCoV Ab waxaa loo soo bandhigay sidii NMPA-dii ugu horreysay ee ay ansixisay IgM/IgG combo antibody test, kaas oo laga soo sheegay CCTV.

    about-us (26)
    about-us (11)

    Imtixaanka Innovita 2019-nCoV Ab ee uu magacaabay Academician Zhong Nanshan

    Galabtii Febraayo 23, 2020, Academician Zhong Nanshan ayaa shaaca ka qaaday intii lagu jiray wadatashi fog oo Guangzhou kula yeeshay kooxda caafimaadka ee Guangdong si ay u caawiyaan Jingzhou in Maamulka Waxsoosaarka Caafimaadka Qaranka uu ansixiyay laba qalab oo cusub oo tijaabo ah 2019-nCoV, mid ka mid ah waa Waxaa soo saaray Innovita (Tangshan) Biological Technology Co., Ltd.

    Xirmada waxa ay isticmaashaa habka dahabka kolooyiinka, kaas oo ogaan kara antibody-ka lgM ee jidhka bukaanka.LgM antibody waxaa la ogaan karaa maalinta 7aad ee caabuqa bukaanka ama maalinta 3aad ee bilawga, taas oo aad u caawinaysa ogaanshaha dheeraadka ah ee bukaanka.Zhong Nanshan wuxuu yiri: "Bukaannada si dhakhso ah ayaa loogu aqoonsan karaa ogaanshaha wanaagsan. Tani waxay naga caawin kartaa inaan si dhakhso ah u kala saarno dadka caadiga ah iyo kuwa cudurka qaba."

    about-us (15)

    Abaalmarinta Wadareed Sare

    about-us (8)

    La dagaalanka Faafa

    Combating Pandemic